Just another WordPress site

Resources

Access a repository of CPPC’s case studies, reports, and original research. Our breadth of valuable information informs and guides your cannabis policy and research needs with a data-driven approach.

Recommended Approaches to Evaluate Methodologies and Technologies for the Detection of Cannabis-Impaired Driving

In September 2023, New York State Department of Health (DOH) issued a Request for Information (RFI) regarding methodologies and technologies used for the detection and assessment of driving under-the-influence of cannabis (DUIC). The RFI purpose is to assist the DOH in assessing the current state of research on impairment due to cannabis ingestion, and to review current devices that can be used to detect impairment. Moreover, the DOH is seeking to identify research institutions in higher education that are currently performing this type of research.

read more

Maryland Medical Cannabis Patient Survey Report 2022

The Maryland Medical Cannabis Commission sponsored this survey and report from Cannabis Public Policy Consulting (CPPC) to examine patterns of use, perceptions of risk and benefit, and occurrence of high-risk
behaviors related to cannabis use in the medical cannabis patient population. More than 13,000 medical cannabis patients took part in the survey, which was conducted in September 2022, prior to the General Election referendum to legalize adult use in the state. A second, post referendum survey is planned for fall 2023.

read more

Maryland Medical Cannabis Patient Survey Report 2023

The Maryland Cannabis Administration (MCA), formerly the Maryland Medical Cannabis Commission (MMCC), sponsored this “post-legalization” survey and report from Cannabis Public Policy Consulting (CPPC) to examine similarities and differences in patient perceptions and behavior prior to and following legalization of cannabis in Maryland for adults 21+. The MMCPS-23 follows the first wave MMCPS-22, a “pre-legalization” survey that was conducted in September 2022, prior to the ballot referendum in which voters approved legalization of the sale of cannabis to adults 21 and over beginning July 1, 2023. As with the MMCPS-22, more than 15,000 patients took part in the MMCPS- 23 survey, conducted in September 2023, approximately three months after the start of adult-use sales in the State. This report details the extent to which key measures of
interest changed with expanded legalization, including patterns of use, perceptions of risk and benefit, and the occurrence of high-risk behaviors related to cannabis use.

read more

Utah Medical Cannabis Patient Demand Study

Cannabis Public Policy Consulting (CPPC) was tasked by the Utah Department of Agriculture and Food with estimating patient demand parameters in Utah’s medical cannabis market. To complete these tasks, CPPC drew upon three survey waves of the Regulatory Determinants of Cannabis Survey (RDCOS) and supply data provided by the Utah Department of Agriculture and Food. The three RDCOS survey waves employed recruited patients throughout the duration of the months of March, June, and September of 2023. Subsequently, this data was compiled across survey waves to engage in inferential and descriptive statistical analysis of the Utah medical cannabis market and medical cannabis patient market behavior.

read more

STAY INFORMED ON CPPC'S RESEARCH AND PROJECTS